OptiNose (OPTN)
(Delayed Data from NSDQ)
$0.86 USD
-0.04 (-4.93%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $0.85 -0.01 (-1.21%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Balance Sheet
Fiscal Year End for OptiNose, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 74 | 94 | 111 | 144 | 147 |
Receivables | 20 | 34 | 35 | 23 | 14 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 8 | 9 | 12 | 9 | 3 |
Other Current Assets | 4 | 3 | 3 | 4 | 4 |
Total Current Assets | 105 | 140 | 160 | 181 | 168 |
Net Property & Equipment | 1 | 1 | 1 | 2 | 3 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 2 | 3 | 4 | 6 | 2 |
Total Assets | 108 | 144 | 166 | 189 | 173 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 4 | 5 | 8 | 5 | 4 |
Current Portion Long-Term Debt | 130 | 129 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 42 | 45 | 51 | 47 | 33 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 177 | 179 | 59 | 52 | 36 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 126 | 125 | 75 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 18 | 22 | 2 | 5 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 194 | 201 | 188 | 182 | 111 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 634 | 628 | 588 | 535 | 490 |
Retained Earnings | -720 | -685 | -610 | -528 | -428 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -87 | -57 | -22 | 7 | 62 |
Total Liabilities & Shareholder's Equity | 108 | 144 | 166 | 189 | 173 |
Total Common Equity | -87 | -57 | -22 | 7 | 62 |
Shares Outstanding | 112.30 | 111.40 | 82.20 | 52.00 | 41.50 |
Book Value Per Share | -0.77 | -0.51 | -0.26 | 0.13 | 1.48 |
Fiscal Year End for OptiNose, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 74 | 67 | 71 | 84 |
Receivables | NA | 20 | 21 | 22 | 17 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 8 | 8 | 8 | 8 |
Other Current Assets | NA | 4 | 2 | 2 | 3 |
Total Current Assets | NA | 105 | 99 | 104 | 112 |
Net Property & Equipment | NA | 1 | 1 | 1 | 1 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 2 | 2 | 2 | 2 |
Total Assets | NA | 108 | 101 | 106 | 115 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 4 | 5 | 6 | 6 |
Current Portion Long-Term Debt | NA | 130 | 130 | 129 | 129 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 42 | 29 | 28 | 31 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 177 | 164 | 164 | 166 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 15 | 11 | 22 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 194 | 179 | 176 | 189 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 634 | 633 | 631 | 630 |
Retained Earnings | NA | -720 | -710 | -701 | -704 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | -87 | -78 | -70 | -74 |
Total Liabilities & Shareholder's Equity | NA | 108 | 101 | 106 | 115 |
Total Common Equity | 0 | -87 | -78 | -70 | -74 |
Shares Outstanding | 112.60 | 112.30 | 112.20 | 112.00 | 111.90 |
Book Value Per Share | 0.00 | -0.77 | -0.69 | -0.62 | -0.66 |